| Document |
Document Title |
|
WO/2021/148620A1 |
The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a...
|
|
WO/2021/126140A1 |
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...
|
|
WO/2021/126142A1 |
An esterification process that uses an acetic acid composition from a wood acetylation process as a reactant. Even though the acetic acid composition contains impurities, such as ethyl acetate, methyl acetate, acetaldehyde, acetone, terp...
|
|
WO/2021/122793A1 |
The present invention relates to disaccharide compounds and their use as enhancers of transmucosal drug uptake.
|
|
WO/2021/122103A1 |
The present invention relates to a method for producing a human milk oligosaccharide (HMO) containing at least one HMO compound, characterized in that an aqueous solution containing the at least one HMO compound and at least one acid is ...
|
|
WO/2021/110709A1 |
Process for the preparation of a galacto-oligosaccharide preparation, which process comprises the step of contacting a lactulose-containing feed with a beta-galactosidase derived from Papiliotrema terrestris. The resulting galacto-oligos...
|
|
WO/2021/107522A2 |
The present application relates to a novel composition for preparing allulose and a method for preparing allulose by using same
|
|
WO/2021/094133A2 |
The present invention relates to a method for producing 2'-fucosyllactose, an enzyme selectively cleaving the alpha-1,3-C-O bond of fucosylated carbohydrates and its use for the production of 2' fucosyllactose, a host cell heterologously...
|
|
WO/2021/094459A1 |
The present invention relates to a method for drying human milk oligosaccharides (HMOs). More specifically, the present invention is related to a method of roller drying or drum drying of human milk oligosaccharides in a simple and econo...
|
|
WO/2021/085317A1 |
The present invention allows cell culturing while the cells are suspended, and is configured for easy recovery of the cultured cells. An additive for suspension culture according to an embodiment is a medium additive that is added to a m...
|
|
WO/2021/075882A1 |
The present invention relates to a coagulant that is added to effectively recover a sugar solution from a saccharified product that contains insoluble saccharified residues composed mainly of lignin, and monosaccharides after acidic sacc...
|
|
WO/2021/075538A1 |
The present invention provides: a crystalline 2,4-crosslinked common intermediate useful for producing a plurality of ENA monomers; a method for stereoselectively producing said intermediate; and a method for efficiently producing indivi...
|
|
WO/2021/066159A1 |
The present invention addresses the problem of providing: a sugar composition suitable for a cyclic tetrasaccharide-containing starch syrup which has low viscosity, low water activity, and low colorability, which is low in calories, and ...
|
|
WO/2021/064629A1 |
The present invention relates to the separation and isolation of neutral human milk oligosaccharides (HMOs) from the reaction milieu in which they are produced, preferably from a fermentation broth, comprising the steps of: i) optionally...
|
|
WO/2021/045968A1 |
This specification relates to a process for preparing a purified human milk oligosaccharide ("HMO") from an HMO-containing solution (e.g., a fermentation broth) by a process comprising removal of an antifoam agent, and a product of such ...
|
|
WO/2021/043540A1 |
Disclosed are non-sporulating Bacillus cells for the production of a sialylated oligosaccharide wherein said Bacillus cell has been genetically engineered to possess a lactose permease, a CMP-NeuNAc biosynthesis pathway and a sialyltrans...
|
|
WO/2021/039833A1 |
The present invention addresses the problem of providing a novel means for preventing the inhibition of the proliferation of keratinocytes even when the keratinocytes begin to contact with each other. The present invention can solve th...
|
|
WO/2020/260028A1 |
The invention relates to a process for separating xylose in the liquid phase from a mixture of C5 and C6 sugars comprising at least xylose and glucose, by adsorbing the xylose on a zeolite adsorbent which is based on FAU zeolite crystals...
|
|
WO/2020/260027A1 |
The invention relates to a process for separating glucose in the liquid phase from a mixture of C5 and C6 sugars comprising at least xylose and glucose, by adsorbing the glucose on a zeolite adsorbent which is based on FAU zeolite crysta...
|
|
WO/2020/249512A1 |
Disclosed are non-sporulating Bacillus cells for the production of a fucosylated oligosaccharide as well as a method for producing a fucosylated oligosaccharide, wherein said Bacillus cell has been genetically engineered to possess a lac...
|
|
WO/2020/243746A1 |
A method has now been found for the preparation of calcium, magnesium, and zinc salts of sugar acids, this being the object of the present invention, which is characterized in that the method may include providing a sugar and oxidizing t...
|
|
WO/2020/233958A1 |
A method for the purification of an oligosaccharide, preferably a neutral human milk oligosaccharide (HMO) or a sialylated HMO, from a fermentation broth, the method comprising: - providing a fermentation broth which contains the oligosa...
|
|
WO/2020/210027A1 |
The disclosure provides for methods of treating pain and neuroinflammatory pain conditions with certain oligosaccharides.
|
|
WO/2020/205034A1 |
Disclosed are a method of preparing a saccharide that contains a 3-fluoro-sialic acid and a method of bonding it to a homogeneous antibody. Also within the scope of this invention are compounds each containing a 3-fluoro-sialic acid, mon...
|
|
WO/2020/191620A1 |
The personal care compositions or cosmetic systems using reduced level or no preservative and/or surfactant, including skin care essences, lotions, creams and moisturizing liquids and uses thereof.
|
|
WO/2020/189859A1 |
The present application relates to a novel allulose-derived compound and an acid-resistant composition comprising same.
|
|
WO/2020/180158A1 |
The present invention relates to a novel compound comprising a galactose trigger moiety and cyclopropabenzindole (CBI), and an antibody-drug conjugate prepared by using same.
|
|
WO/2020/175440A1 |
The present invention provides a method for producing a sugar chain, which achieves an excellent yield of a stereocontrolled sugar chain. The present invention also provides building blocks for sugar donors and for sugar acceptors, which...
|
|
WO/2020/169782A1 |
The present invention relates to modified monosaccharide compounds implemented in methods for labeling and/or detecting an eukaryotic cell from a multicellular organism. It also relates to such modified monosaccharide compounds implement...
|
|
WO/2020/168421A1 |
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...
|
|
WO/2020/148693A1 |
It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for ...
|
|
WO/2020/146523A1 |
Provided herein are compositions of trehalose phospholipids and uses thereof, e.g., compounds and compositions comprising 6,6'-diphosphatidyltrehalose (diPT) and analogs thereof with modifications of the diPT chemical scaffold, that bind...
|
|
WO/2020/141032A1 |
The invention relates to the field of nutritional ingredients, in particular to economically attractive methods for producing hypoallergenic galactooligosaccharides (HA-GOS) and the use thereof in food and feed items. Provided is a metho...
|
|
WO/2020/127156A1 |
The present invention relates to an improved process to produce a specific and very efficient epoxidation-catalyst (1,2:4,5-Di-O-isopropylidene-β-D-erythro-2,3-hexodiulo-2,6-
pyranose).
|
|
WO/2020/127140A1 |
The present invention relates to a method for separating biomass from a solution comprising biomass and at least one oligosaccharide.comprising providing the solution comprising biomass and oligosaccharides.lowering the pH value of the s...
|
|
WO/2020/132096A1 |
The invention provides methods for preparing antibodies and antibody derivatives with controlled levels of core fucosylation. In one aspect, provided herein is a method of controlling the level of afucosylation of an antibody or antibody...
|
|
WO/2020/127417A2 |
The present invention relates to methods for producing 3-fucosyllactose (3-FL) as well as novel fucosyltransferases, more specifically novel lactose binding alpha-1,3-fucosyltransferase polypeptides, and their applications. Furthermore, ...
|
|
WO/2020/114850A1 |
The invention relates to a continuous method for obtaining a crystalline monosaccharide, comprising: continuous crystallization of the monosaccharide in a main crystallizer (10), wherein crystallization by evaporation and/or crystallizat...
|
|
WO/2020/111851A1 |
The present application relates to a method for preparing a D-psicose crystal comprising 98%(w/w) or more of D-psicose and 0.05%(w/w) or less of ethanol on the basis of 100%(w/w) of the entire crystal, the method comprising: a first step...
|
|
WO/2020/098659A1 |
The present invention relates to a method for removing impurities in a xylose mother liquor. A xylose mother liquor produced during xylose production is used as a raw material, and the xylose mother liquor is pretreated by using a lytic ...
|
|
WO/2020/097446A1 |
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to prevent or treat dysfunctions in a gastrointestinal barrier. The present disclosure further relates to methods o...
|
|
WO/2020/097458A1 |
The present disclosure relates oligosaccharide preparations suitable for use in nutritional compositions such as animal feed and methods of manufacturing the described oligosaccharide preparations. The present disclosure further relates ...
|
|
WO/2020/091423A1 |
The present invention provides a novel phytochemical-fructooligosaccharide conjugate having a structure in which a phytochemical in the form of phenolic acid is conjugated to a portion of saccharides constituting a fructooligosaccharide ...
|
|
WO/2020/079146A1 |
Crystalline form II of 2'-O-fucosyl lactose having an X-ray powder diffraction pattern comprising three reflections at 2θ angles (13.65 ± 0.20)°, (16.98 ± 0.20)° and (18.32 ± 0.20)°, determined at a temperature of 25 °C with Cu-K...
|
|
WO/2020/074635A1 |
The present invention describes a syrup of tagatose and galactose as main components together with other secondary products such as glycerol, oligosaccharides and other sugars in a minority amount.
|
|
WO/2020/062156A1 |
Disclosed by the present application is a continuous flow catalytic reactor, an assembling method therefor and an application thereof. The continuous flow catalytic reactor comprises a reaction container, a filler material packaged in th...
|
|
WO/2020/057561A1 |
A method for preparing D-psicose from starch. The starch is used as a raw material, and D-psicose with the purity being 98-99% is obtained by means of saccharification treatment, isomerization treatment, and concentration and chromatogra...
|
|
WO/2020/057562A1 |
A method for producing concentrated D-psicose, including vaporization and concentration using a mechanical vapor recompression evaporator and utilizing flash steam to obtain high-concentration D-psicose.
|
|
WO/2020/057560A1 |
Disclosed is a process for producing D-psicose using starch, comprising the steps of subjecting starch to liquefaction and saccharification to obtain a first mixture; adding enzymatic metal ions into the mixture for isomerization to obta...
|
|
WO/2020/049016A1 |
The invention relates to the field of hypoallergenic oligosaccharides for use in nutritional compositions, in particular to oligosaccharides having prebiotic properties. Provided is a hypoallergenic oligosaccharide composition comprising...
|
